B.A., with highest honors, Princeton; M.D., Columbia; J.D., Georgetown. Prior to matriculating at the Georgetown University Law Center, Professor Cohen was professor of anesthesiology at the University of Pennsylvania Medical Center and professor and chairman of anesthesiology at the Universities of Colorado and Michigan Medical Centers. After receiving his law degree, he worked in health care policy as a special expert for the Medications Development Division in the National Institute on Drug Abuse (NIDA), an institute of the National Institutes of Health. He has written articles dealing with legal/medical ethical issues and has published more than 100 scientific papers (basic and clinical science), four books, medical and law review articles, and chapters in books. Professor Cohen has served as the Vice Chair of NIDA’s Institutional Review Board (IRB); the IRB is responsible for ensuring that NIDA’s clinical studies conform to the highest ethical standards. He chairs the Physicians Health Program of the District of Columbia Medical Society which intervenes on and then coordinates the monitoring and treatment of physicians suffering from drug dependence or alcoholism and is Vice-Chair of the Lawyer Assistance Committee of the DC Bar. Professor Cohen’s publications since joining the Law Center’s faculty include: A Shooting on Capitol Hill: “The Ruby Satellite System,” Mental Illness, and Failure of the American Legal System, 11 Kennedy Institute of Ethics Journal, 391 (2001); Untreated Addiction Imposes an Ethical Bar to Recruiting Addicts for Non-Therapeutic Studies of Addictive Drugs, 30 J. Law, Medicine & Ethics, 73 (2002); Failure to Conduct a Placebo-Controlled Trial May be Unethical, 2 Amer. J. of Bioethics 24 (2002); Required “Volunteers” for Human Investigations—Just Say No! 4 Amer. J. of Bioethics, 55 (2004); DRUGS, ADDICTION, AND THE LAW: POLICY, POLITICS, AND PUBLIC HEALTH (Carolina Academic Press, Durham, NC, 2004); Science, Politics, and the Regulation of Dietary Supplements—It’s Time to Repeal DSHEA, 31 AMER. J. LAW & MED. 175 (2005); Medical Marijuana, Compassionate Use, and Public Policy—Expert Opinion or Vox Populi, 36 Hastings Center Review 19 (2006); Comment—Fentanyl Abuse and Dependence: Further Evidence for Second Hand Exposure Hypothesis, 25 J. Addict. Dis. 135 (2006); Addiction, Molecules, and Morality: Disease Does Not Obviate Responsibility, 7 American Journal of Bioethics 21-23 (2007); Just Deserts? 37 Hastings Center Report 5 (2007); Medical Marijuana—A Clash of Science, Politics, and the Law, 14 Lahey Clinic Journal of Medical Ethics 4 (2007); The Many Faces of Drugs—A Personal Perspective, in DRUGS AND JUSTICE Foreword (Margaret P. Battin, et al. Editors, Oxford University Press, New York 2007); Vigilance and the Drug-Dependent Anesthesiologist, 110 ANESTHESIOLOGY 1422 (2009); Medical Marijuana—The Conflict Between Scientific Evidence and Political Ideology, 23 Journal of Pain & Palliative Care Pharmacotherapy (in two parts) 4 and 120 (2009); and Medical Marijuana—The Conflict Between Scientific Evidence and Political Ideology, 2009 UTAH L. REV. 35 (2009).